Searched for
ANTI PROFITEERING CELL
'Don't die in the meantime': Millionaire Bryan Johnson says some humans may live forever, shares three reasons whyLongevity advocate Bryan Johnson predicts a future where humans might live indefinitely, driven by rapid advancements in biotech and AI. He...- Will Jio IPO finally get a date today? What to expect from Mukesh Ambani at RIL AGMReliance Industries shareholders eagerly await Mukesh Ambani's address at the 49th AGM, seeking a definitive Jio IPO date as the company's ...
- Waaree Energies shares in focus as Q2 net profit more than doubles to Rs 842 croreWaaree Energies reported a significant 133% surge in net profit to Rs 842 crore for the September quarter, fueled by a 70% revenue jump to ...
- From snacks to ACs, GST 2.0 brings price relief for common manWith the implementation of GST 2.0, consumers can anticipate lower prices on various products as businesses pass on reduced tax rates. Food...
- Biocon urges government to exempt cancer, rare-disease drugs from tax in budgetIndia should eliminate tax on drugs for cancer treatment and chronic diseases, urged Biocon's chairperson Kiran Mazumdar-Shaw, ahead of the...
- 'Jai Palestine': Can AIMIM's Asaduddin Owaisi be disqualified for raising the slogan? Here’s what the Constitution saysAIMIM leader Asaduddin Owaisi praised Palestine after taking his oath in the 18th Lok Sabha, sparking an uproar and leading to calls for hi...
- BJP may go for LS polls in December 2023, has booked all choppers for campaigning: Mamata BanerjeeWest Bengal Chief Minister Mamata Banerjee on Monday said that the BJP might conduct the Lok Sabha polls in December itself, claiming that ...
- Exide Industries expects to regain pre-covid margin in 1-2 yearsExide Industries plans to regain its pre-pandemic EBITDA margin of 13-14% within the next one to two years after its current margin reached...
- Russia: Alexei Navalny’s ally Vadim Ostanin jailed for 9 years over ‘extremism’; Here’s what happened.Over the past month, Alexei Navalny, a prominent critic of the Kremlin, has been facing a trial in secret at the IK-6 penal colony in Melek...
- Xiaomi's India biz turns around, revenue grows over 9% in FY22Xiaomi turned around its India business in FY22 with the company's turnover growing more than 9% to Rs 39,099 crore, topping the pre-pandem...
- Auto Expo 2023: Ashok Leyland showcases future of commercial vehicle industryThe Company, which has been a forerunner in introducing cutting-edge technologies, demonstrated its futuristic vehicle range, powered by el...
- India terminates anti-dumping probe into solar cell imports from China, Thailand & VietnamOn May 15, 2021, the ministry's investigation arm Directorate General of Trade Remedies (DGTR) initiated a probe into alleged dumping of "s...
- DGTR gets extension for completion of anti-dumping probe on solar cell imports from China, Thailand, Vietnam"The competent authority has accepted the request of extending time for completing the on-going anti-dumping (original) investigation on im...
- Biocon says use of Itolizumab in COVID-19 treatment encouragingBiocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pha...
- Jakson Group to invest Rs 700 crore to set up new solar plantThe firm, which has a small 70 MW manufacturing plant in Greater Noida at present, is confident about competing with Chinese imports.
- Biocon rolls out its first biologic drug for the treatment of psoriasisCalled ALZUMAb, it took 10 years in the making and "is recognition of innovation done by research and development wing of Biocon," said Kir...
- Taking the toxin out of your cancer treatmentRA Sengupta and Shiladitya Mashelkar have set up a Delhi-based co, Invictus Oncology, to take a modified Cisplatin to the market.
- Rel Life Sciences to focus on R&D, for nowThe company is all set to launch fifth biosimilar drug and seeks approvals for clinical trials and stem-cell treatment.
- Reliance Life plans to launch biosimilar drug in EuropeMukesh Ambani-owned Reliance Life Sciences to launch biosimilar drug in Europe within a year since it has completed all required testing an...
- Not Music To Ears: Mobile chip piracy rings in Rs 200-crore lossThe Indian Music Industry (IMI) says the total loss to music industry due to piracy is around 600-700 crores per year, out of which music p...
Load More
